[1] |
Fishbein MC.The vulnerable and unstable atherosclerotic plaque[J].Cardiovasc Pathol,2010,19(1):6-11.
|
[2] |
周刚,于吉星.冠状动脉病变与颈动脉粥样硬化的相关性分析[J].中西医结合心血管病杂志,2019,7(9):30-31.
|
[3] |
高华,陈枫,王玉玲.血浆胱抑素C、同型半胱氨酸水平与大动脉粥样硬化型脑梗死的相关性[J].检验医学与临床,2017,14(21):3222-3224.
|
[4] |
符杰,邓红艳,胡嫚丽,等.血清胱抑素C 及趋化素水平与2 型糖尿病亚临床动脉粥样硬化的关系[J].中华医学杂志,2019,99(4):307-311.
|
[5] |
张如梦,薛东章,王轶群,等.胱抑素C 与高血压性脑出血及其颈动脉粥样硬化斑块的相关性研究[J].蚌埠医学院学报,2019,44(2):196-198,201.
|
[6] |
陈桂青,王石林,陈树丹,等.老年高血压患者血浆同型半胱氨酸及超敏C 反应蛋白水平与颈动脉粥样硬化的相关性[J].中国临床保健杂志,2018,21(3):353-356.
|
[7] |
陈国栋,刘兵荣,肖瑾,等.胱抑素C、同型半胱氨酸与颈动脉斑块稳定性的相关性[J].中国神经免疫学和神经病学杂志,2014,21(1):32-35.
|
[8] |
Suzuki Y,Matsushita K,Yoshida T,et al.Clinical validity of renal function markers including serum cystatin C on chronic kidney disease classification[J].Rinsho Byori,2011,59(4):345-351.
|
[9] |
Inker LA,Levey AS,Coresh J.Estimated glomerular filtration rate from a panel of filtration markers-hope for increased accuracy beyond measured glomerular filtration rate?[J].Adv Chronic Kidney Dis,2018,25(1):67-75.
|
[10] |
Wang B,Sun J,Kitamoto S,et al.Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors[J].J Biol Chem,2006,281(9):6020-6029.
|
[11] |
周明锴,程倚萌.急性脑梗死患者血清同型半胱氨酸与胱抑素C 水平相关性分析[J].中国实用神经疾病杂志,2013,16(5):24-25.
|
[12] |
Kobayashi T,Yokokawa H,Fujibayashi K,et al.Association between high cystatin C levels and carotid atherosclerosis[J].World J Cardiol,2017,9(2):174-181.
|
[13] |
杨松,蒋颖,吴坚.缺血性脑卒中患者胱抑素C 与颈动脉粥样硬化的关系[J].中华老年心脑血管病杂志,2013,15(10):1021-1023.
|
[14] |
Yetkin E,Waltenberger J.Cathepsin enzymes and cystatin C:do they play a role in positive arterial remodeling?[J].Stroke,2009,40(2):26-27.
|
[15] |
Staun-Ram E,Miller A.Cathepsins(S and B)and their inhibitor Cystatin C in immune cells:modulation by interferon-beta and role played in cell migration[J].J Neuroimmunol,2011,232(1-2):200-206.
|
[16] |
刘琰凤,吐尔逊·沙比尔.缺血性脑卒中患者血清胱抑素C 与颈动脉粥样硬化间关系的研究进展[J].中国动脉硬化杂志,2016,24(9):969-972.
|
[17] |
张蓉.急性脑梗死患者血浆胱抑素C、同型半胱氨酸水平与颈动脉粥样硬化的相关性分析[J].实用心脑肺血管病杂志,2014,22(10):28-30.
|
[18] |
Bengtsson E,To F,Hakansson K,et al.Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice[J].Arterioscler Thromb Vasc Biol,2005,25(10):2151-2156.
|
[19] |
Sukhova GK,Wang B,Libby P,et al.Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice[J].Circ Res,2005,96(3):368-375.
|
[20] |
Zhu Y,Zhang HP,Wang YC,et al.Serum cystatin C level is associated with carotid intima-media thickening and plaque[J].Scand J Clin Lab Invest,2015,75(3):265-272.
|
[21] |
陈涛,王应良,王一萍,等.胱抑素C、同型半胱氨酸、超敏C 反应蛋白和D-二聚体联合检测动脉粥样硬化性脑梗死的临床意义[J].中国临床神经科学,2013,21(5):562-565.
|
[24] |
王金行,刘青鹏,刘柏新,等.急性心肌梗死患者血清胱抑素C 和同型半胱氨酸的水平变化[J].中国老年学杂志,2013,33(7):1626-1628.
|
[25] |
罗国忠,贺海文,杨永成,等.颈动脉斑块稳定性与胱抑素C 及同型半胱氨酸的相关研究分析[J].国际检验医学杂志,2015,36(19):2850-2851.
|
[22] |
Zhao L,Zhai Z,Hou W.Analysis of carotid color ultrasonography and high sensitive C-reactive protein in patients with atherosclerotic cerebral infarction[J].Pak J Med Sci,2016,32(4):931-934.
|
[23] |
Sukhova GK,Wang B,Libby P,et al.Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice[J].Circ Res,2005,96(3):368-375.
|
[26] |
Hashimoto T,Shinohara Y,Hasegawa H.Homocysteine metabolism[J].Yakugaku Zasshi,2007,127(10):1579-1592.
|
[27] |
梁小宁.血浆同型半胱氨酸与缺血性脑血管病患者颈动脉粥样硬化斑块的关系[J].临床医学研究与实践,2018,(9):38-39.
|
[28] |
郭亚丽.血清Hcy、CysC 及hs-CRP 水平检测在动脉粥样硬化中的临床意义[J].临床医学,2017,37(12):8-10.
|
[29] |
Mccully KS.Hyperhomocysteinemia,suppressed immunity,and altered oxidative metabolism caused by pathogenic microbes in atherosclerosis and dementia[J].Front Aging Neurosci,2017,9:324.
|
[30] |
邓宇鲲,闫冰,陈涛,等.血浆同型半胱氨酸水平与颈动脉斑块相关性的研究[J].中国循环杂志,2014,29(5):363-366.
|
[31] |
王雅琼,张斌.脑梗死患者血清Hcy、UA、FBG 和BP 与颈动脉粥样硬化斑块的关系[J].江苏医药,2016,42(8):931-933.
|
[32] |
许寅宏,徐恩,林清原,等.血清同型半胱氨酸与脑梗死患者颈动脉粥样硬化斑块稳定性的关系[J].中风与神经疾病杂志,2014,31(7):603-605.
|
[33] |
Dietrich M,Jacques PF,Polak JF,et al.Segment-specific association between plasma homocysteine level and carotid artery intima-media thickness in the framingham offspring study[J].J Stroke Cerebrovasc Dis,2011,20(2):155-161.
|
[34] |
李蒙蒙,朱明肃,李轩,等.急性脑梗死患者血清胆红素、同型半胱氨酸与颈动脉粥样硬化斑块性质的关系[J].医学研究与教育,2019,36(1):13-16.
|
[35] |
Alsulaimani S,Gardener H,Elkind MS,et al.Elevated homocysteine and carotid plaque area and densitometry in the northern manhattan study[J].Stroke,2013,44(2):457-461.
|
[36] |
Hoke M,Amighi J,Mlekusch W,et al.Cystatin C and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis[J].Stroke,2010,41(4):674-679.
|
[37] |
Jiao B,Zhang YH,Cheng YN,et al.A low-dose combination of valsartan and low molecular weight heparin better improved glomerular permeability than did high-dose monotherapy in rats with diabetic nephropathy[J].Drug Discov Ther,2011,5(3):119-124.
|
[38] |
曹明英,姚朱华,郑权秀,等.强化他汀治疗对ACS 患者PCI 围手术期胱抑素C 和炎症反应的影响[J].中华急诊医学杂志,2014,23(7):761-764.
|
[39] |
甄志刚,汪立燕,王晋朝,等.急性脑梗死TOAST 分型的相关研究进展[J].实用心脑肺血管病杂志,2011,19(9):1433-1434.
|